MAPT and tauopathy: To determine whether similar pathogenesis occurs in DA neurons that express htauWT, we used three common phosphoepitope antibodies (AT8, AT100, and AT180) and a polyclonal anti-tau antibody that have been widely utilized to characterize AD-like abnormal phosphorylation of tau in the postmortem brains of AD patients and animal models of tauopathies.